Zhang Q, Minoda K
Department of Ophthalmology, Teikyo University Ichihara Hospital, Chiba, Japan.
Jpn J Ophthalmol. 1995;39(4):432-7.
Gene diagnosis is essential for confident presymptomatic prediction, genetic counseling, and early management of hereditary retinoblastoma. In screening the leukocyte DNA of three patients with bilateral retinoblastoma for RB1-gene heterozygous germline mutations, we identified mutations involving exon 3 or 18 of the RB1 gene by using heteroduplex analysis and sequencing. In one case the mutation was a 2 bp GT deletion resulting in the loss of the exon 18 splicing-donor; another mutation was a G-to-T transversion at codon 580 in exon 18, which converts Arg to a stop codon. The third mutation involved in 1 bp deletion at codon 96 in exon 3, which leads to a premature stop codon at codon 110. We used information from this heteroduplex technique for genetic counseling and presymptomatic prediction. A newborn was identified as normal, using gene diagnosis; his 15-month follow-up confirmed our prediction.
基因诊断对于遗传性视网膜母细胞瘤的可靠症状前预测、遗传咨询及早期管理至关重要。在对三名双侧视网膜母细胞瘤患者的白细胞DNA进行RB1基因杂合种系突变筛查时,我们通过异源双链分析和测序鉴定出涉及RB1基因外显子3或18的突变。在一个病例中,突变是2个碱基对GT缺失,导致外显子18剪接供体缺失;另一个突变是外显子18中第580密码子处的G到T颠换,将精氨酸转换为终止密码子。第三个突变涉及外显子3中第96密码子处1个碱基对缺失,导致第110密码子处提前出现终止密码子。我们利用这种异源双链技术的信息进行遗传咨询和症状前预测。一名新生儿经基因诊断被确定为正常;对其15个月的随访证实了我们的预测。